We are pleased to announce the release of a groundbreaking research paper titled "Characterisation of the Cardiovascular Effects of a Meal: QTcF Assessment and Further Insights into the Physiological Effects," authored by Dr. Georg Ferber, Dr. Dilshat Djumanov, Dr. Ulrike Lorch, Dr. Edward Jackson, Dr. Joao Almeida Melo, Mr. James Rickard, and Dr. Jorg Taubel. 

This collaborative effort between Statistik Georg Ferber GmbH, Richmond Pharmacology Ltd, St George’s University of London, King’s College London and Richmond Research Institute delves into the intricate relationship between meals and the QT interval on an electrocardiogram (ECG), particularly when corrected for heart rate using Fridericia's formula (QTcF). 

The study explores the impact of meals on QTcF intervals in the context of integrating Pharmacology studies and Thorough QT (TQT) investigations, providing crucial insights into the potential implications for cardiac health and the risk of arrhythmias. The comprehensive meta-analysis, based on data from nine studies conducted in accordance with ethical standards, sheds light on meal effect QTcF changes, offering valuable perspectives for cardiac safety assessment in clinical trials and drug development. 

The findings also hold promise for more patient-focused practices, contributing to the global fight against antimicrobial resistance (AMR) through the potential reduction of exposure to harmful challenge agents. This research marks a significant step forward in our understanding of the impact of meals on cardiovascular health and aims to accelerate the pace and safety of drug development processes.

Latest news

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

February 17, 2025
We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...
Read more

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

February 10, 2025
The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Latest news

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

February 17, 2025
We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...
Read more

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

February 10, 2025
The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event